Increased Expression of Protease-Activated Receptors 2 Indicates Poor Prognosis in HBV Related Hepatocellular Carcinoma

Infectious Agents and Cancer - United Kingdom
doi 10.1186/s13027-019-0256-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CELSR3 mRNA Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2019English

Correction: Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma Through Induction of OCT4/NANOG Expression

Clinical Cancer Research
Cancer ResearchOncology
2016English

Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients

OncoTargets and Therapy
OncologyPharmacology
2016English

Decreased DC‑SIGNR Expression in Hepatocellular Carcinoma Predicts Poor Patient Prognosis

Oncology Letters
Cancer ResearchOncology
2019English

Downregulation of GNA14 in Hepatocellular Carcinoma Indicates an Unfavorable Prognosis

Oncology Letters
Cancer ResearchOncology
2020English

Low STYK1 Expression Indicates Poor Prognosis in Gastric Cancer

Cancer Management and Research
Oncology
2018English

Upregulation of Circulating PD-L1/PD-1 Is Associated With Poor Post-Cryoablation Prognosis in Patients With HBV-Related Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2011English

Mitofusin-2 Acts as Biomarker for Predicting Poor Prognosis in Hepatitis B Virus Related Hepatocellular Carcinoma

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2018English

Co-Expression of LASS2 and TGF-β1 Predicts Poor Prognosis in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy